No abstract available
Keywords:
bladder cancer; enfortumab vendotin; immunotherapy.
MeSH terms
-
Carcinoma, Transitional Cell*
-
Humans
-
Immunotherapy
-
Urinary Bladder Neoplasms* / diagnosis
-
Urinary Bladder Neoplasms* / epidemiology
-
Urinary Bladder Neoplasms* / therapy